Impact of anemia on outcomes in on-pump coronary artery bypass surgery patients

Aim    To study the contribution of preoperative anemia to the prognosis of adverse clinical events (mortality, complications, transfusion) in patients with ischemic heart disease (IHD) after myocardial revascularization in the conditions of artificial circulation.
Material and methods    This retrospective cohort study included 1 133 patients with IHD who had undergone isolated myocardial revascularization in the conditions of artificial circulation in 2019. The primary endpoints were mortality and a composite endpoint that included, in addition to mortality, cases of acute coronary syndrome, heart, respiratory and renal failure, neurological deficit, and infectious complications. The secondary endpoints were duration of artificial ventilation of more than 12 h, duration of stay in the resuscitation and intensive care unit (RICU) of more than one day, and duration of postoperative inpatient treatment of more than 7 days. 
Results    Preoperative anemia was found in 196 (17.3 %) patients. The anemia was not associated with mortality but increased the risk of the composite endpoint, prolonged artificial ventilation, stay in RICU for more than one day, and red blood cell transfusion. Despite the absence of a relationship between red blood cell transfusion and mortality, the use of transfusion was associated with increased risks of the composite endpoint and prolonged stay in the RICU and hospital.
Conclusion    Preoperative anemia is a risk factor for adverse outcomes of myocardial revascularization in the conditions of artificial circulation. Timely treatment of preoperative anemia may improve outcomes of the treatment.

1. Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G. Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery. The Annals of Thoracic Surgery. 2013;96(2):478–85. DOI: 10.1016/j.athoracsur.2013.03.015

2. Hung M, Besser M, Sharples LD, Nair SK, Klein AA. The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients. Anaesthesia. 2011;66(9):812–8. DOI: 10.1111/j.1365-2044.2011.06819.x

3. Miceli A, Romeo F, Glauber M, de Siena PM, Caputo M, Angelini GD. Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. Journal of Cardiothoracic Surgery. 2014;9(1):137. DOI: 10.1186/1749-8090-9-137

4. Joshi S, George A, Manasa D, Savita HemalathaMR, Krishna PrasadTH, Jagadeesh A. Propensity-matched analysis of association between preoperative anemia and in-hospital mortality in cardiac surgical patients undergoing valvular heart surgeries. Annals of Cardiac Anaesthesia. 2015;18(3):373–9. DOI: 10.4103/0971-9784.159808

5. Spiegelstein D, Holmes SD, Pritchard G, Halpin L, Ad N. Preoperative Hematocrit as a Predictor of Perioperative Morbidities Following Nonemergent Coronary Artery Bypass Surgery. Journal of Cardiac Surgery. 2015;30(1):20–6. DOI: 10.1111/jocs.12458

6. Salisbury AC. Diagnostic Blood Loss From Phlebotomy and Hospital-Acquired Anemia During Acute Myocardial Infarction. Archives of Internal Medicine. 2011;171(18):1646–53. DOI: 10.1001/archinternmed.2011.361

7. Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. The Lancet. 2002;359(9319):1747–8. DOI: 10.1016/S0140-6736(02)08614-2

8. Van Straten AHM, Soliman Hamad MA, van Zundert AJ, Martens EJ, Schönberger JPAM, de Wolf AM. Preoperative Hemoglobin Level as a Predictor of Survival After Coronary Artery Bypass Grafting: A Comparison With the Matched General Population. Circulation. 2009;120(2):118–25. DOI: 10.1161/CIRCULATIONAHA.109.854216

9. LaPar DJ, Hawkins RB, McMurry TL, Isbell JM, Rich JB, Speir AM et al. Preoperative anemia versus blood transfusion: Which is the culprit for worse outcomes in cardiac surgery? The Journal of Thoracic and Cardiovascular Surgery. 2018;156(1):66-74.e2. DOI: 10.1016/j.jtcvs.2018.03.109

10. Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG et al. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function: Impaired contractility in iron-deficient cardiomyocytes. European Journal of Heart Failure. 2018;20(5):910–9. DOI: 10.1002/ejhf.1154

11. Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. American Journal of Hematology. 2017;92(10):1068–78. DOI: 10.1002/ajh.24820

12. Spahn DR, Schoenrath F, Spahn GH, Seifert B, Stein P, Theusinger OM et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. The Lancet. 2019;393(10187):2201–12. DOI: 10.1016/S0140-6736(18)32555-8

13. Mamadaliev D.M., Farkhutdinov F.F., Shestakov E.A., Gudymovich V.G., Elizarenko R.V., Zhiburt E.B. Preoperative risk factors of anemic syndrome and red cell transfusion in cardiac surgery. Bulletin of Pirogov National Medical and Surgical Center. 2015;10(2): 27–31.

14. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. 2010;4:CD001888. DOI: 10.1002/14651858.CD001888.pub4

15. Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. The Lancet. 2003;361(9352):161–9. DOI: 10.1016/S0140-6736(03)12195-2

16. Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery. Circulation. 2007;116(22):2544–52. DOI: 10.1161/CIRCULATIONAHA.107.698977

17. Vlot EA, Verwijmeren L, van de Garde EMW, Kloppenburg GTL, van Dongen EPA, Noordzij PG. Intra-operative red blood cell transfusion and mortality after cardiac surgery. BMC Anesthesiology. 2019;19(1):65. DOI: 10.1186/s12871-019-0738-2

18. Ranucci M, Di Dedda U, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Impact of Preoperative Anemia on Outcome in Adult Cardiac Surgery: A Propensity-Matched Analysis. The Annals of Thoracic Surgery. 2012;94(4):1134–41. DOI: 10.1016/j.athoracsur.2012.04.042

19. Zhou X, Xu Z, Wang Y, Sun L, Zhou W, Liu X. Association between storage age of transfused red blood cells and clinical outcomes in critically ill adults: A meta-analysis of randomized controlled trials. Medicina Intensiva. 2019;43(9):528–37. DOI: 10.1016/j.medin.2018.07.004

20. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Critical Care Medicine. 2006;34(6):1608–16. DOI: 10.1097/01.CCM.0000217920.48559.D8

21. Kuduvalli M, Oo A, Newall N, Grayson A, Jackson M, Desmond M et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. European Journal of Cardio-Thoracic Surgery. 2005;27(4):592–8. DOI: 10.1016/j.ejcts.2005.01.030

22. Paone G, Likosky DS, Brewer R, Theurer PF, Bell GF, Cogan CM et al. Transfusion of 1 and 2 Units of Red Blood Cells Is Associated with Increased Morbidity and Mortality. The Annals of Thoracic Surgery. 2014;97(1):87–94. DOI: 10.1016/j.athoracsur.2013.07.020

23. Creteur J, Neves A, Vincent J-L. Near-infrared spectroscopy technique to evaluate the effects of red blood cell transfusion on tissue oxygenation. Critical Care. 2009;13(Suppl 5):S11. DOI: 10.1186/cc8009

24. Nielsen ND, Martin-Loeches I, Wentowski C. The Effects of red Blood Cell Transfusion on Tissue Oxygenation and the Microcirculation in the Intensive Care Unit: A Systematic Review. Transfusion Medicine Reviews. 2017;31(4):205–22. DOI: 10.1016/j.tmrv.2017.07.003

25. Cabrales P, Ortiz D, Friedman JM. NO supplementation for transfusion medicine and cardiovascular applications. Future Science OA. 2015;1(1):fso.15.51. DOI: 10.4155/fso.15.51

26. Bordbar A, Johansson PI, Paglia G, Harrison SJ, Wichuk K, Magnusdottir M et al. Identified metabolic signature for assessing red blood cell unit quality is associated with endothelial damage markers and clinical outcomes. Transfusion. 2016;56(4):852–62. DOI: 10.1111/trf.13460

27. Yurkovich JT, Zielinski DC, Yang L, Paglia G, Rolfsson O, Sigurjónsson ÓE et al. Quantitative time-course metabolomics in human red blood cells reveal the temperature dependence of human metabolic networks. Journal of Biological Chemistry. 2017;292(48):19556–64. DOI: 10.1074/jbc.M117.804914

28. Helms CC, Gladwin MT, Kim-Shapiro DB. Erythrocytes and Vascular Function: Oxygen and Nitric Oxide. Frontiers in Physiology. 2018;9:125. DOI: 10.3389/fphys.2018.00125

29. Barshtein G, Arbell D, Yedgar S. Hemodynamic Functionality of Transfused Red Blood Cells in the Microcirculation of Blood Recipients. Frontiers in Physiology. 2018;9:41. DOI: 10.3389/fphys.2018.00041

30. D’Alessandro A, Reisz JA, Zhang Y, Gehrke S, Alexander K, Kanias T et al. Effects of aged stored autologous red blood cells on human plasma metabolome. Blood Advances. 2019;3(6):884–96. DOI: 10.1182/bloodadvances.2018029629

31. Baron-Stefaniak J, Leitner GC, Küntzel NKI, Meyer EL, Hiesmayr MJ, Ullrich R et al. Transfusion of standard-issue packed red blood cells induces pulmonary vasoconstriction in critically ill patients after cardiac surgery – A randomized, double-blinded, clinical trial. PLOS ONE. 2019;14(3):e0213000. DOI: 10.1371/journal.pone.0213000

32. Yoshida T, Prudent M, D’Alessandro A. Red blood cell storage lesion: causes and potential clinical consequences. Blood Transfusion. 2019;17(1):27–52. DOI: 10.2450/2019.0217-18

33. Akselrod B.A., Balashova E.N., Bautin A.E., Bakhovadinov B.B., Biryukova L.S., Bulanov A.Yu. et al. Clinical guidelines for red blood cell transfusion. Russian journal of hematology and transfusiology. 2019;63(4):372–435. DOI: 10.25837/HAT.2019.62.39.006